Speakers on a panel are considerong the possibility of applying a drug design similar to ones emerging from the Alzheimers disease and cancer communities. The feasibility of applying such a model will be considered with the biology of the disease, regulatory concerns and pharma needs in mind.
Aubrey de Grey
Christy Carter, University of Florida
Andrew Martello, Spoonful of sugar
Camillo Ricordi, University of Miami
Christy Carter is trying to solve and prevent Sarcopenia (the loss of muscle tissue as we age)
50% of the loss of strength is the loss of muscle and 50% is something else
FDA is having problems allowing for regulation and treatment without clearer definitions of what is going on.
researchers are trying to use behaviorial definitions
Looking at rapamycin for treatment
Dynapenia for muscle weakness
Christy is very hopeful about using SARMS (safe steroids) for fighting sarcopenia.
Myostatin inhibitors have a lot of buzz but the clinical tests are not showing significant sustained strength gains.
Andrew Martello, Spoonful of sugar
Need to guide the clinician on the prescription of the procedure that the patient can actually follow
Need to understand why the people are not engaging with the procedure.
How much do I need it
What are my concerns
Need care package that optimizes the patients engagement with the procedures
Spoonful of Sugar is the only specialist medicines-related behaviour consultancy conceived from the 15-year research programme of Professor Rob Horne of University College London (UCL), the internationally recognised expert in self-management of chronic illness and adherence to medications. Spoonful of Sugar is supported by UCL Business, a wholly-owned subsidiary of UCL formed to help industry and business make the most of the university’s innovations.
Spoonful of Sugar is the brainchild of Prof. Rob Horne and Andrew Martello. They met and formed a long-standing working relationship when Andrew was championing the patient voice within the pharmaceutical industry and Rob was progressing his ground-breaking behavioural research programme. They realised that there was a way to bring their two worlds together and apply Rob’s research to real-world interventions
The unique business model of Spoonful of Sugar allows our consultancy to draw on world-leading published and ongoing research to inform intelligent solutions applied in real-world settings
Spoonful of Sugar -PHARMACEUTICAL INDUSTRY
Making sure medicines are used in the best possible way for the best possible results
[SOS] create research based bespoke programmes to ensure patients get the right support, in the right way, that affects change
Pharmaceutical companies value our unique expertise and solutions that ensure their products are used in appropriate and optimal ways
[SOS] recognise that products will not be perceived as effective in the real world and will not achieve the desired health outcomes if they are not taken as prescribed
Brian Wang is a Futurist Thought Leader and a popular Science blogger with 1 million readers per month. His blog Nextbigfuture.com is ranked #1 Science News Blog. It covers many disruptive technology and trends including Space, Robotics, Artificial Intelligence, Medicine, Anti-aging Biotechnology, and Nanotechnology.
Known for identifying cutting edge technologies, he is currently a Co-Founder of a startup and fundraiser for high potential early-stage companies. He is the Head of Research for Allocations for deep technology investments and an Angel Investor at Space Angels.
A frequent speaker at corporations, he has been a TEDx speaker, a Singularity University speaker and guest at numerous interviews for radio and podcasts. He is open to public speaking and advising engagements.